Pleural Effusion, Malignant: Clinical Trials

10 trials for Pleural Effusion, Malignant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 1 active not recruiting, 1 terminated. 10 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 310Completed 8, Active not recruiting 1, Terminated 1

Follow Pleural Effusion, Malignant: new trials by email Literature Review of Pleural Effusion, Malignant trials Research Report on Pleural Effusion, Malignant

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Phase Ⅲ Clinical Study of Combined Cisplatin Versus Placebo Combined With Intracavitary Cisplatin Injection in the Treatment of Malignant Pleural Effusions
ENDOSTAR,cisplatin, Placebo , cisplatin - Malignant Pleural Effusion
Phase 3Active not recruitingJiangsu Simcere Pharmaceutical Co., Ltd.2902021-07-282026-01-02
Efficacy of Iodopovidone Versus Talc in Palliative Malignant Pleural Effusion
Iodopovidone solution, Talc - Malignant Pleural Effusion
Phase 3CompletedChiang Mai University602015-11-012020-01-23
Efficacy and Safety Study of Abnoba Viscum F 20mg in Malignant Pleural Effusion Patients
Abnoba Viscum F 20mg - Malignant Pleural Effusion
Phase 3CompletedAbnoba Korea682011-01-012014-07-23
Intrapleural Bevacizumab and Cisplatin Therapy for Malignant Pleural Effusion Caused by Non-small Cell Lung Cancer
Bevacizumab, Cisplatin - Malignant Pleural Effusion
Phase 3CompletedChinese PLA General Hospital722009-08-012015-03-25
Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy
Darbepoetin alfa, Placebo - Non-Small Cell Lung Cancer, Anemia
Phase 3TerminatedAmgen25492009-07-172022-11-30
A Prospective, Randomized Controlled Trial for a Rapid Pleurodesis Protocol for the Management of Pleural Effusions
Thoracoscopy and Pleurx, Thoracoscopy - Malignant Pleural Effusions
Phase 3CompletedSingapore General Hospital1202008-09-012017-02-10
Video-Assisted Surgery or Talc Pleurodesis in Treating Patients With Malignant Mesothelioma
talc, therapeutic thoracoscopy, therapeutic videothoracoscopy - Malignant Mesothelioma, Metastatic Cancer
Phase 3CompletedPapworth Hospital NHS Foundation Trust1962003-09-012013-06-28
Standard Chest Tube Compared With a Small Catheter in Treating Malignant Pleural Effusion in Patients With Cancer
talc, dyspnea management - Metastatic Cancer, Pulmonary Complications
Phase 3CompletedAlliance for Clinical Trials in Oncology672002-05-012016-07-04
Bleomycin, Doxycycline, or Talc in Treating Patients With Malignant Pleural Effusions
bleomycin sulfate, doxycycline, talc - Metastatic Cancer
Phase 3CompletedEastern Cooperative Oncology Group4801997-01-102023-06-22
Talc in Treating Patients With Malignant Pleural Effusion
talc, Talc - Metastatic Cancer
Phase 3CompletedAlliance for Clinical Trials in Oncology5011994-12-012016-06-28

Narrower conditions

Neoplasm Metastasis (4)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Anemia (1)  ·  Lung Neoplasms (1)  ·  Mesothelioma, Malignant (1)  ·  Neoplasms (1)  ·  Pleural Effusion (1)  ·  Solitary Fibrous Tumor, Pleural (1)

Broader conditions

Neoplasms by Site (10)  ·  Pleural Diseases (10)  ·  Pleural Neoplasms (10)  ·  Respiratory Tract Diseases (10)  ·  Respiratory Tract Neoplasms (10)  ·  Thoracic Neoplasms (10)  ·  Neoplasms (9)  ·  Pleural Effusion (9)  ·  Neoplastic Processes (4)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Lung Diseases (3)  ·  Bronchial Neoplasms (2)  ·  Carcinoma, Bronchogenic (2)  ·  Lung Neoplasms (2)

Interventions

Talc (5)  ·  Cisplatin (2)  ·  Bevacizumab (1)  ·  Bleomycin (1)  ·  Darbepoetin alfa (1)  ·  Doxycycline (1)  ·  Povidone-Iodine (1)  ·  Thoracoscopy (1)  ·  viscum album peptide (1)

Sponsors

Alliance for Clinical Trials in Oncology (2)  ·  Abnoba Korea (1)  ·  Amgen (1)  ·  Chiang Mai University (1)  ·  Chinese PLA General Hospital (1)  ·  Eastern Cooperative Oncology Group (1)  ·  Jiangsu Simcere Pharmaceutical Co., Ltd. (1)  ·  Papworth Hospital NHS Foundation Trust (1)  ·  Singapore General Hospital (1)

Countries

China (3)  ·  United States (3)  ·  Canada (2)  ·  South Korea (2)  ·  United Kingdom (2)  ·  Argentina (1)  ·  Austria (1)  ·  Belgium (1)  ·  Brazil (1)  ·  Bulgaria (1)  ·  Chile (1)  ·  Croatia (1)  ·  Czechia (1)  ·  Germany (1)  ·  Greece (1)

Top investigators

Apichat Tantraworasin (1)  ·  Devanand Anantham, FCCP (1)  ·  Friedemann Schad, MD (1)  ·  Jemi Olak, MD (1)  ·  Jin Li, Doctor (1)  ·  John C. Ruckdeschel, MD (1)  ·  Kook Joo Na, MD (1)  ·  Nan Du (1)  ·  Randolph S. Marks, MD (1)  ·  Robert Winter, MD (1)  ·  Shukui Qin, Doctor (1)  ·  Todd Demmy, MD (1)  ·  Yeong Dae Kim, MD (1)  ·  YongJik Lee, MD (1)

Results publications

PMID 15764775, PMID 14973997, PMID 16478853, PMID 17567670, PMID 24942631

NIH funding

U10CA031946 (1), U10CA076001 (1)